Maximal tolerated dose determined for venetoclax in combination with liposomal vincristine in patients with relapsed or refractory ph- negative T-cell or B-cell acute lymphoblastic leukemia: Results of phase 1 portion of ECOG-ACRIN EA9152 Meeting Abstract
| Authors: | Palmisiano, N.; Lee, J. W.; Claxton, D. F.; Paietta, E.; Alkhateeb, H. B.; Park, J. H.; Podoltsev, N.; Atallah, E. L.; Schaar, D. G.; Dinner, S.; Webster, J.; Luger, S. M.; Litzow, M. R. |
| Abstract Title: | Maximal tolerated dose determined for venetoclax in combination with liposomal vincristine in patients with relapsed or refractory ph- negative T-cell or B-cell acute lymphoblastic leukemia: Results of phase 1 portion of ECOG-ACRIN EA9152 |
| Meeting Title: | 63rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 138 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2021 Dec 11-14 |
| Meeting Location: | Atlanta, GA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2021-11-23 |
| Language: | English |
| ACCESSION: | WOS:000736413905224 |
| DOI: | 10.1182/blood-2021-153621 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3407 -- Hybrid meeting, also took place online -- Source: Wos |
